Women will spend approximately one-third of their lives after the menopause transition and approximately 6,000 women reach ...

The potential market for the Novartis drug Kisqali could grow markedly, now that certain early-stage breast cancer patients ...

Adjuvant cancer treatments such as chemotherapy and radiation are given after a primary cancer treatment to help prevent ...

Hormone replacement therapy could be a major key to unlocking health benefits for women going through menopause, according to ...

New data released today at The Menopause Society's annual meeting shows fewer people are opting for hormone replacement ...

The use of hormone therapy to ease menopause symptoms continues to decline in the United States, despite research showing ...

Postmenopausal women with a history of hormone therapy use have slower biological aging compared to those who never used the ...

Less than 2% of women are taking hormone therapy for menopause symptoms, likely due to a past study that raised safety ...

Biological age vs chronological age was younger among postmenopausal female individuals who received hormone replacement therapy.

A new meta-analysis presented at the 2024 Annual Meeting of The Menopause Society suggests that hormone therapy could ...

The single biggest barrier to HT use, and overall menopause care, is the need for provider training, according to researchers ...

There are some long-term benefits, too: Taking HT within six years of starting menopause may help reduce your risk of heart ...